NeoHeadHunter: an algorithm for the detection, ranking and probabilistic classification of neoepitope candidates
Abstract
BackgroundThe manufacturing of personalized cancer vaccine requires the accurate identification of neoepitopes, abnormal peptides presented by cancer cells and recognized by the host immune system of the cancer patient. ResultsWe designed and developed NeoHeadHunter, a computational algorithm and pipeline to detect and rank neoepitope candidates. Unlike other algorithms, NeoHeadHunter can estimate the probability that each predicted neoepitope candidate is true positive. To evaluate NeoHeadHunter, we used the Tumor neoantigEn SeLection Alliance (TESLA) data-set derived from the sequencing of nine patients and characterized by 44 experimentally validated positive neoepitopes, a data-set derived from the sequencing of three cancer patients and characterized by eight experimentally validated positive neoepitopes and a manually curated data-set consisting of 64 experimentally validated positive neoepitopes. Our evaluation shows that NeoHeadHunter performs the best compared with other algorithms for both detecting and ranking neoepitope candidates and that NeoHeadHunter can accurately predict such probabilities. ConclusionsNeoHeadHunter can increase the effectiveness of personalized cancer vaccine by sensitively detect, accurately rank and probabilistically classify neoepitope candidates. NeoHeadHunter is released under the APACHE-II license at https://github.com/XuegongLab/neoheadhunter for academic use.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- In vitro validation of neoantigen prediction algorithm for developing personalized cancer vaccine therapy
Y.-j. Choe, E. Kim, … S. Paik·bioRxiv·Dec 12, 2021
- Population-level distribution and putative immunogenicity of cancer neoepitopes
M. A. Wood, M. Paralkar, … R. F. Thompson·BMC CancerPeer-reviewed·Apr 13, 2018
- ProTECT: Prediction of T-cell Epitopes for Cancer Therapy
Arjun Arkal Rao, Ada A. Madejska, … David H. Haussler·Frontiers in ImmunologyPeer-reviewed·Nov 10, 2020
- DeepPROTECTNeo: A Context-aware Personalized and Reverse Vaccinology-guided Deep Learning Framework for Immunogenicity Prediction
Debraj Das, Soumyadeep Bhaduri, Pralay Mitra·bioRxiv·Jan 4, 2025
- Prioritizing candidate peptides for cancer vaccines by PEPPRMINT: a statistical model to predict peptide presentation by HLA-I proteins
Laura Y. Zhou, Fei Zou, Wei Sun·bioRxiv·Sep 24, 2021
- Discovery of prevalent, clinically actionable tumor neoepitopes via integrated biochemical and cell-based platforms
H. Gurung, A. J. Heidersbach, … C. M. Rose·bioRxiv·Oct 27, 2022